The aims of the study were to characterize the vibration-induced nystagmus (VIN) in patients with unilateral vestibular neuritis (VN) and Ménière’s disease (MD), and to clarify the clinical significance of VIN by comparing it with caloric results in patients with VN and MD. We recorded eye movements from 22 VN patients and 24 MD patients using unilateral 100-Hz vibration on the mastoid bone. Eye movements were analyzed and the maximum value of slow-phase eye velocity was obtained during vibration on each mastoid. The average value of slow-phase velocities was calculated. Spontaneous nystagmus was subtracted from the slow-phase velocity, whenever it was present. A canal paresis (CP) greater than 25% was considered pathologic. All but one VN patient showed pathologic CP with the direction of the slow-phase eye movement of VIN toward the lesioned side. Fifteen (63%) out of 24 MD patients showed VIN with the slow-phase eye movement directed to the lesioned side. Pathologic CP was present in 9 (38%) out of 24 MD patients and 8 of them showed slow-phase eye movements of VIN directed to the lesioned side. There were also 8 other MD patients who showed slow-phase eye movement of VIN directed to the intact side. Among them, 3 patients with the slow-phase eye movement more than 5°/s showed CP on the intact side. The amplitude of slow-phase eye velocity showed a significant correlation with CP in patients with either VN or MD. There was no significant difference in the slope of the regression lines between the VN and MD groups. Our results suggest that VIN may probe imbalance of canal responses to low-frequency stimulation similar to the caloric test. It also shows that VIN can help in detecting vestibular imbalance using a stimulation mechanism different from the caloric test. The VIN test can be helpful in determining the lesioned side in patients with VN; however, it has some limitations in localizing the lesioned side in patients with MD.

Hamann KF, Schuster EM: Vibration-induced nystagmus – a sign of unilateral vestibular deficit. ORL J Otorhinolaryngol Relat Spec 1999;61:74–79.
Hudspeth AJ: Mechanoelectrical transduction by hair cells of the bullfrog’s sacculus. Prog Brain Res 1989;80:129–135.
Karlberg M, Aw ST, Black RA, Todd MJ, MacDougall HG, Halmagyi GM: Vibration-induced ocular torsion and nystagmus after unilateral vestibular deafferentation. Brain 2003;126:956–964.
Mateijsen DJ, Hengel PW, Kingma H, Oreel MA, Wit HP, Albers FW: Vertigo and electronystagmography in uni- and bilateral Meniere’s disease. ORL J Otorhinolaryngol Relat Spec 2001;63:341–348.
Minor LB, Goldberg JM: Influence of static head position on the horizontal nystagmus evoked by caloric, rotational and optokinetic stimulation in the squirrel monkey. Exp Brain Res 1990;82:1–13.
Monsell EM, Balkany TA, Gates GA, et al: Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg 1995;113:181–185.
Ohki M, Murofushi T, Nakahara H, Sugasawa K: Vibration-induced nystagmus in patients with vestibular disorders. Otolaryngol Head Neck Surg 2003;129:255–258.
Park HJ, Migliaccio AA, Della Santina CC, Minor LB, Carey JP: Search-coil head-thrust and caloric tests in Meniere’s disease. Acta Otolaryngol 2005;125:852–857.
Park HJ, Shin JE, Shim DB: Mechanisms of vibration-induced nystagmus in normal subjects and patients with vestibular neuritis. Audiol Neurotol 2007;12:189–197.
Popov KE, Lekhel H, Faldon M, Bronstein AM, Gresty MA: Visual and oculomotor responses induced by neck vibration in normal subjects and labyrinthine-defective patients. Exp Brain Res 1999;128:343–352.
Strupp M, Arbusow V, Dieterich M, Sautier W, Brandt T: Perceptual and oculomotor effects of neck muscle vibration in vestibular neuritis. Ipsilateral somatosensory substitution of vestibular function. Brain 1998;121:677–685.
Yagi T, Ohyama Y: Three-dimensional analysis of nystagmus induced by neck vibration. Acta Otolaryngol 1996;116:167–169.
Young ED, Fernandez C, Goldberg JM: Responses of squirrel monkey vestibular neurons to audio-frequency sound and head vibration. Acta Otolaryngol 1977;84:352–360.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.